Previous Article | Next Article ![]()
Infection and Immunity, January 2003, p. 140-146, Vol. 71, No. 1
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.1.140-146.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Microbiology II, Jikei University School of Medicine, Minato-ku, Tokyo 105-8461, Japan
Received 15 April 2002/ Returned for modification 3 August 2002/ Accepted 16 October 2002
|
|
|---|
5 and ß1 chains were associated with the cytoskeleton. Cytosolic signaling factors such as paxillin, c-Src, and c-Csk were also associated with the cytoskeleton. On the contrary, ß3 integrin transiently disappeared from the cytoskeleton when macrophages ingested the fibronectin-treated S. aureus Cowan I. Furthermore, the Src kinase family tyrosine kinase Lyn dissociated from the cytoskeleton. These cellular components did not respond in a fibronectin-dependent manner when macrophages phagocytosed S. saprophyticus. This means that only fibronectin-treated S. aureus Cowan I induces the accumulation of very late antigen 5, which in turn induces the association of paxillin and tyrosine kinases. It is thought that the phagocytic activity of macrophages against fibronectin-treated S. aureus was increased by signaling via the activation of very late antigen 5. |
|
|---|
A previous study showed that S. aureus Cowan I and two clinically isolated coagulase-negative staphylococci (CNS) expressing both FN-binding proteins, FnBPA and B, bound FN on their surfaces to similar extents. However, the number of bacteria ingested by macrophages increased only when the macrophages interacted with FN-bound S. aureus, whereas FN showed no effect on the ingestion of CNS (37). In the present study, the response of the adhesion architecture of macrophages after binding to FN-bound staphylococci was investigated.
|
|
|---|
Macrophages. Macrophages were obtained as previously described (37). In brief, 1 ml of 3% thioglycolate medium (Difco, Detroit, Mich.) was injected intraperitoneally into female ICR mice (5 weeks of age; purchased from Charles River Japan Inc.), and peritoneal exudate cells were collected on day 4 by flushing the cavity with 3 ml of ice-cold Dulbecco's modified Eagle's medium (Life Technologies, Grand Island, N.Y.). The cells were washed twice, suspended in HEPES-buffered RPMI 1640 medium and plated onto plastic petri dishes (Nunc, Roskilde, Denmark). After 2 h of incubation at 37°C in a humidified atmosphere of 5% CO2 and 95% air, nonadherent cells were removed by rinsing. HEPES-buffered RPMI medium was then added to the cultures. The cell monolayers were found to contain >98% macrophages as determined from their morphology by use of a Giemsa stain or histochemical stain for nonspecific esterase.
Preparation of FN from fetal calf serum. FN from fetal calf serum was prepared as previously described (37). Before the use of FN, gel-filtered fractions eluted by cellulofine GCL-2000-m (Seikagaku Co., Tokyo, Japan) were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under nonreducing conditions and fractions containing only dimers were selected, because spontaneous multimer formation sometimes occurred.
Quantification of ingested staphylococci in the presence of GRGDSP and GRADSP peptides and anti-VLA 5 antibody. Staphylococci (1010 CFU) were suspended in 200-µg/ml FN dissolved in PBS(+) and were incubated for 1 h at 37°C. Bacteria were then washed three times with PBS(+). FN-treated bacteria were added to the macrophage cultures at a bacteria/macrophage ratio of 500 to 1. Before the addition of bacteria, a peptide with a GRGDSP or GRADSP sequence was added to the cultures at various concentrations. In another experiment, monoclonal anti-mouse very late antigen 5 (VLA-5) antibody (Chemicon International Inc., Temecula, Calif.) was added at various dilutions. After ingestion for 40 min, the cultures were washed with saline and treated with 20 µg of lysostaphin/ml for 30 min at 37°C to lyse bacteria outside of the macrophages. When bacteria were not completely lysed under this condition, as was especially the case with S. saprophyticus, the period of lysostaphin treatment was prolonged up to 45 min or 40 µg of lysostaphin/ml was used. The cultures were then washed, fixed with absolute methanol, and stained by Giemsa solution. Two hundred macrophages were selected randomly, and the number of ingested bacteria was counted under a light-field microscope (Nikon Optiphot-2). Statistical significance was evaluated by Student's t test.
Preparation of the cytoskeletal fraction from macrophages and Western blot analysis of associated proteins.
Macrophages which ingested the FN-treated or untreated bacteria were treated with 0.1% Triton X-100 solution containing 0.1 M sodium chloride, 1 mM EDTA, 10 mM piperazine-N-N'-bis(2-ethanesulfonic acid) (PIPES) (pH 7.0), 10 mM sodium orthovanadate, and protease inhibitors for 1 min at 37°C to solubilize the cytosolic fraction. The remaining Triton X-100-stable cytoskeletal fraction was dissolved in 0.1% SDS buffer with (for detection of ß1 integrin,
5 integrin, paxillin, and tyrosine kinases) or without (for detection of ß3 integrin) 0.1 M 2-mercaptoethanol, sonicated in ice-water, and boiled. These samples were separated by SDS-PAGE and transferred to Immobilon-P membranes (Millipore Co., Bedford, Mass.). In all of these experiments, proteins corresponding to 105 cells were loaded in each lane. The membranes were blocked and then treated with the first antibody followed by treatment with horseradish peroxidase-conjugated or alkaline phosphatase-conjugated secondary antibodies. Antibodies were purchased from the following companies: anti-ß1 integrin, Chemicon International Inc.; anti-ß3 integrin, Genex (Helsinki, Finland); anti-
5 integrin, anti-Src, anti-Csk, and anti-Lyn, Santa Cruz Biotechnology Inc. (Santa Cruz, Calif.); and anti-phosphotyrosine (4G10), Upstate Biotechnology Inc. (Lake Placid, N.Y.). Quantification of signals was performed with a Densitograph AE-6920 M-FX (Atto Co., Tokyo, Japan). The intensity values of protein signals on a blot were analyzed by an image-analyzing system equipped with a Densitograph. This system calibrates the different background intensities among different blots.
Immunoprecipitation. Proteins were immunoprecipitated from cell lysate supernatants by using goat anti-VLA-5 antibody. FN-treated or untreated HLj or FN-treated S. saprophyticus was added to the macrophage cultures as described above. After 2 or 20 min, cells were washed with ice-cold PBS and lysed with a solution containing 1% Nonidet P-40, 0.15 M sodium chloride, 1 mM EDTA, 2 mM sodium orthovanadate, 2 mM sodium pyrophosphate, 10 mM sodium fluoride, and protease inhibitors. Cell lysates were rotated gently for 1 h at 4°C and centrifuged. Cleared supernatants were pretreated with goat IgG followed by protein G-agarose. Centrifuged supernatants were treated with anti-VLA-5 antibody followed by protein G-agarose. Precipitates were boiled in 0.1% SDS buffer, and the supernatants were subjected to SDS-PAGE. The separated proteins were blotted onto a membrane and then examined by Western blot analysis.
|
|
|---|
vß3, which is known as a vitronectin receptor, also interacts with FN via binding to the RGD sequence (42). To determine the participation of the RGD sequence in the phagocytosis of FN-treated staphylococci, the effect of the RGD-containing peptide GRGDSP was examined, and the results are shown in Table 1. As described above, FN treatment increased the number of ingested Cowan I cells but did not affect the ingestion of S. saprophyticus. GRGDSP peptide suppressed the number of ingested FN-treated Cowan I cells in a peptide concentration-dependent manner. In contrast, this peptide had little effect on the ingestion of untreated Cowan I or that of S. saprophyticus regardless of FN treatment. In another experiment, an analogue peptide with a GRADSP sequence was investigated. This peptide had no effect on the phagocytosis of FN-treated Cowan I by macrophages, as the mean number of ingested bacteria per macrophage (± standard deviation) without the peptide was 78.4 ± 56.2 and that with 1 µg of GRADSP peptide/ml was 82.6 ± 45.0 (P = 0.57). These results indicate that the FN receptor, which recognizes the RGD sequence, is associated with the FN-dependent ingestion of S. aureus Cowan I. Thus, VLA-5 or
vß3 may be the FN receptor mediating the FN-dependent ingestion. To determine which receptor was responsible for this function, the effect of anti-VLA-5 antibody was investigated (Table 1). Addition of anti-VLA-5 antibody suppressed the ingestion of FN-treated Cowan I, but not that of untreated Cowan I, in a dose-dependent manner. In the case of S. saprophyticus, this antibody did not affect ingestion irrespective of FN treatment. This suggests that VLA-5 on macrophages is responsible for the FN-activated ingestion of S. aureus Cowan I. |
View this table: [in a new window] |
TABLE 1. Effect of RGD peptide and anti-VLA-5 on the ingestion of FN-treated staphylococci
|
5 integrin. The association of this integrin was not seen up to 5 min after the ingestion of untreated Cowan I, but a signal appeared at 20 min. FN-treated Cowan I, however, rapidly induced the association at 1 min after the start of ingestion (the level of association was five times greater than that of untreated bacteria). This seems to be in good agreement with the association of ß1 integrin with the cytoskeleton. The results shown in Table 1 and Fig. 1 suggest that the integrin responsible for the enhancement of FN-treated Cowan I ingestion is VLA-5, although this integrin seems to function even when macrophages ingest untreated Cowan I or S. saprophyticus. The receptor consisting of ß3 integrin does not function in the FN-dependent ingestion of Cowan I; nevertheless, this integrin also responds in an FN-independent manner.
![]() View larger version (45K): [in a new window] |
FIG. 1. Association of integrins with the macrophage cytoskeleton upon ingestion of staphylococci. The Triton-stable cytoskeletal fraction was prepared from macrophages which ingested FN-treated or untreated S. aureus Cowan I or S. saprophyticus 10312. The association of ß1, ß3, and 5 integrins with this fraction was analyzed by Western blot analysis. (A and B) Signals of ß1 (A) and ß3 (B) integrins in the cytoskeletal fraction of macrophages that ingested Cowan I or S. saprophyticus. (C) 5 integrin in the cytoskeleton of Cowan I-ingesting macrophages. The position of the 5 signal is shown by the black line at left. The lower-molecular-mass signals were nonspecific signals of the first antibody.
|
![]() View larger version (32K): [in a new window] |
FIG. 2. At 20 min after the start of ingestion, tyrosine-phosphorylated proteins in the cytoskeletal fractions from macrophages that ingested FN-treated or untreated Cowan I were examined by Western blot analysis. Lane 1, no treatment; lane 2, 200 µg of FN/ml added to macrophage culture; lane 3, untreated Cowan I added to macrophage culture; lane 4, FN-treated Cowan I added to macrophage culture. Bars at the left side of each lane indicate the signals (with molecular masses in kilodaltons indicated) mentioned in the text.
|
![]() View larger version (35K): [in a new window] |
FIG. 3. Association of paxillin with the cytoskeleton and VLA-5 after ingestion of FN-treated staphylococci. (A to C) Paxillin in the cytoskeletal fractions from macrophages that ingested FN-treated or untreated Cowan I (A), that were treated with 200 µg of FN/ml (B), and that ingested FN-treated or untreated S. saprophyticus 10312 (C) were analyzed by Western blot analysis. (D) Immunoprecipitation of S. aureus- or S. saprophyticus-treated macrophage lysates by anti-VLA-5 antibody. S. aureus HLj with or without FN treatment or FN-treated S. saprophyticus was added to the macrophage culture for 2 min. Macrophage lysates were prepared and immunoprecipitated with anti-VLA-5 antibody as described in Materials and Methods. The immunoprecipitates were subjected to Western blot analysis with anti-paxillin antibody or anti- 5 antibody.
|
5 integrin were detected. However, the precipitate from macrophages ingesting FN-treated HLj contained more paxillin, including a higher-molecular-mass component, than did the other precipitates. This result indicates that VLA-5 quickly formed the complex containing paxillin, especially the 68-kDa isoform, when macrophages started to ingest FN-treated S. aureus.
Analysis of the action of the tyrosine kinases Src, Lyn, and Csk in macrophages.
As shown in Fig. 2, some proteins whose molecular masses were approximately 60 kDa were tyrosine phosphorylated after exposure to FN-treated Cowan I. Since the molecular masses of many nonreceptor tyrosine kinases are within this range and some kinases are known to associate with the focal contact apparatus (48), we investigated the action of tyrosine kinases. Figure 4A shows the results of Western blot analysis of Src kinase associated with the cytoskeletal fraction. In nontreated macrophages, a small amount of kinase was present in this fraction. Ingestion of untreated Cowan I did not result in much increase in the amount of Src; however, in macrophages ingesting FN-treated Cowan I, this kinase increased to twice the level present in macrophages ingesting untreated Cowan I, even at 1 min after the start of ingestion. In the case of S. saprophyticus, FN treatment did not affect the association of this kinase with the cytoskeletal fraction. Another tyrosine kinase, Csk, which is known to regulate the activity of the Src kinase family (28), also started to associate with the cytoskeleton only in macrophages that ingested FN-treated Cowan I (with association beginning at 1 min and continuing until 10 min after ingestion), whereas untreated Cowan I did not induce a rapid association (Fig. 4B). These results suggest that Src and Csk respond in a manner similar to that of
5 and ß1 integrins in macrophages ingesting FN-treated S. aureus. The association of Lyn with the cytoskeleton in Cowan I-ingesting macrophages is shown in Fig. 4C. This kinase belongs to the Src kinase family and is known to be highly expressed in hematopoietic cells (43). Two isoforms, of 56 and 53 kDa, are known to result from alternative splicing (49). In untreated macrophages, both isoforms were associated with the cytoskeletal fraction, but the 53-kDa isoform disappeared from the fraction at 5 min after the start of ingestion of FN-treated Cowan I (but not of untreated Cowan I). This result suggests that the 53-kDa Lyn also functions during the FN-mediated ingestion of Cowan I.
![]() View larger version (38K): [in a new window] |
FIG. 4. Association of Src (A), Csk (B), and Lyn (C) with the cytoskeleton in macrophages that ingested FN-treated or untreated Cowan I or S. saprophyticus as indicated.
|
|
|
|---|
5 and ß1 chains were shown to be associated with the cytoskeletal structure immediately after the ingestion of FN-treated S. aureus Cowan I. Since
5 and ß1 chains were also associated with the cytoskeleton after the ingestion of untreated S. aureus, VLA-5 seems to participate in this ingestion, although the association was very slow compared with that seen upon ingestion of FN-treated Cowan I. Furthermore, this integrin was implicated in the ingestion of S. saprophyticus because its association with the cytoskeleton was similar to that seen upon ingestion of untreated S. aureus. It has been demonstrated that some surface molecules, such as teichoic acid or lipoteichoic acid on staphylococci, seem to bind to integrin (7); hence, the response of
5 and ß1 integrins observed upon the ingestion of untreated S. aureus or S. saprophyticus may have been caused by direct interaction between the integrin and surface molecules of these bacteria. The amount of ß3 integrin in the cytoskeletal fraction did not increase after the addition of S. aureus; in contrast, this integrin transiently disappeared from the fraction upon the addition of bacteria in an FN-independent manner. This indicates that
vß3 does not have an essential function in the FN-enhancing ingestion of S. aureus Cowan I. The contrasting behaviors of ß1 and ß3 integrins with regard to association with the cytoskeleton upon FN-treated S. aureus ingestion may reflect cross talk between ß1 and ß3 integrin functions, that is, one integrin influences the function of another integrin, as has been demonstrated to occur between
5ß1 and
vß3 (2, 39). In S. saprophyticus, the amount of ß3 integrin increased regardless of FN treatment. It is possible that interaction between S. saprophyticus and macrophages is mediated by
vß3 and that a surface molecule on the bacteria, not FN, is responsible for the interaction.
Previous reports have demonstrated that integrins which accumulate at the focal contact region in the adherent cell associate with FAK and tensin and that binding of the accumulated integrins with ECM induces the association of additional components constituting the adhesion apparatus, including talin and paxillin, which mediate the interaction of integrins with the cytoskeletal structure (47). These factors are tyrosine phosphorylated to associate with the apparatus and for regulation of their activity (48). The present study shows that FN-treated S. aureus Cowan I immediately induced a number of tyrosine-phosphorylated proteins in the cytoskeleton and the association of paxillin with the cytoskeleton, whereas untreated Cowan I and FN-treated and untreated S. saprophyticus did not bring about such intense paxillin-cytoskeleton interaction. Two paxillin isoforms with molecular masses of approximately 65 and 68 kDa were observed. Judging from their molecular masses and from the results of a previous report demonstrating that the
isoform is absent from murine tissues (23), the higher- and lower-molecular-mass isoforms are thought to be
and ß paxillin, respectively. It has been established that ß isoform takes part in cell movement (24). In nonstimulated cells, only the lower-molecular-mass component was associated with the cytoskeleton. Only in the case of FN-treated Cowan I, but not FN alone or bacteria alone, was the quick and marked accumulation of both isoforms in the early period of ingestion observed. In this period, VLA-5 formed complexes containing both isoforms of paxillin, indicating that FN bound to the S. aureus surface enables VLA-5 to form an adherent apparatus, as described above.
In the present study, we also found rapid association of Src and Csk with the cytoskeleton and slow dissociation of 53-kDa Lyn from the cytoskeleton in macrophages that ingested FN-treated S. aureus Cowan I. This suggests that FN-enhanced ingestion of S. aureus was regulated by these tyrosine kinases. It is known that various molecules concerned with signal transduction accumulate in the integrin-mediated focal adhesion apparatus (11, 18, 30). In macrophages, it has been reported that adhesion to ECM via integrin causes activation of Src kinases (26). Binding of paxillin in the adhesion apparatus is regulated by the cytoplasmic tyrosine kinases c-Src and c-Csk (14, 35, 47, 48). Furthermore, it is reported that Lyn is tyrosine phosphorylated after adhesion of macrophages to FN via ß1 integrin (26). The fact that FN-treated S. aureus but not FN-treated S. saprophyticus strongly induced the responses of these intracellular signaling factors and VLA-5 suggests that the structural basis of FN binding to S. aureus and that to S. saprophyticus are quite different and that FN bound on S. aureus possibly forms multimers, which induce the ligation of integrins and their interaction with the cytoskeleton and signaling factors as well as ECM, whereas FN on CNS does not form such structures. If this is the case, then it is thought that the "outside-in signal" via VLA-5 is transmitted into macrophages by FN bound on S. aureus so that phagocytic activity is enhanced (3). In this case, ingestion would be mediated by another phagocytic receptor, for example, Fc receptor or complement receptor. Another possibility is that VLA-5, like other phagocytic receptors, directly wraps up FN-bound S. aureus. A previous report demonstrated that
5 and ß1 integrins are present in endocytic vesicles and are recycled by an intracellular trafficking system in polymorphonuclear neutrophils (33). Also, in our preliminary study, we observed a large amount of
5 integrin in detergent-permeabilized macrophages compared with that in untreated cells. This suggests that
5 integrins in macrophages are also recycled together with trafficking vesicles. In this case, FN-bound S. aureus would be incorporated into macrophages via recycled integrins. These possibilities are now being investigated.
It has been demonstrated that certain kinds of bacteria modulate host cell function. With enteropathogenic Escherichia coli, interaction of intimin with host epithelial cells triggers tyrosine phosphorylation of some signaling factors and actin assembly beneath the bacteria, followed by bacterial infection (17). With Bordetella pertussis, the RGD sequence in filamentous hemagglutinin interacts with integrin CR3 (
Mß2 and CD11b/CD18) to adhere to the host cells (34). Invasin, the outer membrane protein in Yersinia spp., interacts with VLA-5 to enter the host cells efficiently (8). By using Ipa proteins, Shigella flexneri invades cells via VLA-5 (45). These previous findings suggest that systems to modulate or utilize host cell function constitute a useful mechanism for survival in host cells. In addition to these intracellular pathogens, a variety of extracellular pathogens are known to enter host cells and survive within them. Streptococcus pyogenes is internalized into epithelial cells through interactions among FN, bacterial FN-binding proteins, and VLA-5 (4). This is thought to be one of the reasons for the frequent failure of ß-lactam antibiotics to eradicate these organisms from infected patients. It has been reported that host cells such as fibroblasts or epithelial cells ingest S. aureus (5, 27). Some strains of S. aureus escape from endosomes and induce apoptosis of these cells (1, 27). Internalization of S. aureus within epithelial cells depends on the expression of FnBP and on tyrosine kinase activity in the host cells (5). This internalization is inhibited by the addition of anti-ß1 integrin antibody (6). It has also been demonstrated that FnBP deletion mutants lose their invasiveness, that expression of FnBP confers invasiveness, that soluble FnBP blocks invasion, and that anti-
5 antibody blocks invasion into epithelial cells (40). It has been reported that FnBP (FnBPA in particular) mediates the invasion of S. aureus into endothelial cells via
5ß1 (22). From these observations, it can be concluded that FnBP on S. aureus must play a major role in the interaction of bacteria with integrins on host cells through FN. Furthermore, it is probable that another factor related to FnBP or FN binding may be expressed on S. aureus, because different signals were observed between macrophages ingesting S. aureus and those ingesting CNS, although both staphylococci possess FnBPs and bind FN equally as previously described (37).
We thank Y. Yasui and T. Iwasaki for their excellent assistance in the preparation of the manuscript.
|
|
|---|
vß3 suppression of calcium/calmodulin-dependent protein kinase II regulates
5ß1 function. J. Cell Biol. 145:889-897.
5ß1-fibronectin-M1 protein complexes. Proc. Natl. Acad. Sci. USA 97:2858-2863.
with actin filaments and focal adhesion kinase. J. Cell Biol. 129:831-842.
1. Infect. Immun. 65:2528-2536.[Abstract]
isoform and developmentally specific ß isoform expression. J. Biol. Chem. 273:22435-22441.
5ß1 in motile neutrophils. Blood 95:2471-2481.
Mß2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375-1382.[CrossRef][Medline]
vß3 integrin regulates
5ß1-mediated cell migration toward fibronectin. J. Biol. Chem. 272:29380-29389.
5ß1. Cell. Microbiol. 1:101-107.[CrossRef][Medline]
vß3)-ligand interaction. J. Biol. Chem. 265:2168-2172.
5ß1 integrin promotes entry of the bacteria into mammalian cells. J. Exp. Med. 183:991-999.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»